Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696] |
| |
Authors: | Petr Ostadal David Alan Petr Hajek Jiri Vejvoda Martin Mates Peter Blasko Josef Veselka Milan Kvapil Jiri Kettner Martin Wiendl Ondrej Aschermann Josef Slaby Eduard Nemecek Frantisek Holm Marek Rac Milan Macek Jana Cepova |
| |
Institution: | 1. German Clinic for Diagnostic, Wiesbaden, Germany
|
| |
Abstract: | Background Stent length serves as a predictor of restenosis in use of bare metal stents (BMS). This has been demonstrated in a feasibility study that used a single short BMS implant (<9 mm) in a high proportion of lesions; the study observed a low rate of restenosis. Methods We performed a pilot prospective study to investigate in a series of consecutive patients the immediate and long-term effects of implantation of either 1) a single short BMS for all lesions with low probability of restenosis or 2) a drug-eluting stent (DES) for all other lesions. Results The 200 patients studied had 236 coronary artery lesions that were treated with short BMS in 168/236 patients (71.2%) and with DES in 68/236 patients (28.8%). Angiographic success was achieved in 230/236 lesions (97.5%) and procedural success in 194/200 patients (97.0%). Restenosis occurred in 15/153 lesions (9.8%) after short BMS, in 3/62 lesions (4.8%) after DES, and in 18/215 of all lesions (8.4%) angiographically controlled after six to eight months. Target vessel revascularization was performed in 16/218 lesion (7.4%). Conclusion Most of the coronary artery lesions in this small group of consecutive patients were treated sufficiently with a single BMS implant. This differential approach of treating suitable lesions in medium- to large-sized vessels with a single short BMS device and treating all other lesions with a DES implant resulted in a low incidence of restenosis. |
| |
Keywords: | statin fluvastatin acute coronary syndrome C-reactive protein interleukin 6 pregnancy-associated plasma protein A |
本文献已被 SpringerLink 等数据库收录! |